Akebia Therapeutics Announces Rare Kidney Pipeline Presentations at ASN Kidney Week

Akebia Therapeutics announced that its rare kidney pipeline, including Vafseo® (vadadustat), will be highlighted through late-breaking presentations and posters at ASN Kidney Week 2026. Additional presentations will focus on Vafseo® clinical and economic data.